The groundbreaking success of Viagra undeniably revolutionized the drug landscape, but investing in companies heavily reliant on off-patent versions presents a challenging picture. Although early earnings were https://pharma862517.techionblog.com/42085170/sildenafil-and-big-pharma-a-risky-bet